Sitagliptin compared with thiazolidinediones as a third-line oral antihyperglycemic agent in type 2 diabetes mellitus

Endocrine Practice

Volumn 17, Issue 5, 2011, Pages 691-698

  Hsia, Stanley H ^a   Navar, Maria D ^a   Duran, Petra ^a   Shaheen, Magda ^a   Davidson, Mayer B ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; HEMOGLOBIN A1C; METFORMIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; ROSIGLITAZONE; SITAGLIPTIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DISEASE DURATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; ETHNIC GROUP; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT CHANGE;

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PYRAZINES; THIAZOLIDINEDIONES; TREATMENT OUTCOME; TRIAZOLES; YOUNG ADULT;

EID: 80054059841     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP10405.OR     Document Type: Article

References (22)

1. Janka GE. Hemophagocytic syndromes. Blood Rev. 2007; 21:245-253.
2. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol. 1991; 18:29-33.
3. Janka GE, Stadt U. Familial and acquired hemophago-cytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program. 2005:82-88.
4. Maakaroun NR, Moanna A, Jacob JT, Albrecht H. Viral infections associated with haemophagocytic syndrome. Rev Med Virol. 2010;20:93-105.
5. Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: Characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages. Blood. 2005;105:1648-1651.
6. Wardeh R, Gu M. Cytologic diagnosis of hemophagocytic lymphohistiocytosis in ascitic fluid: A case report. Acta Cytol. 2008;52:481-484.
7. Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C. Infections associated with haemo-phagocytic syndrome. Lancet Infect Dis. 2007;7:814-822.
8. Shabbir M, Lucas J, Lazarchick J, Shirai K. Secondary hemophagocytic syndrome in adults: A case series of 18 patients in a single institution and a review of literature. Hematol Oncol. 2011;29:100-106.
9. Henter JI, Samuelsson-Horne A, Aricò M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow trans-plantation. Blood. 2002;100:2367-2373.
10. Nagashima T, Yamada K, Uono M, Tsubaki T, Morimatsu Y, Nagashima K. Chronic recurrent demyeli-nating encephalomyelitis associated with hemophagocytic lymphohistiocytosis. Acta Neuropathol. 1983;59:25-30.
11. Watabe R, Shibata K, Hirase N, et al. Angiotropic B-cell lymphoma with hemophagocytic syndrome associated with syndrome of inappropriate secretion of antidiuretic hor-mone. Ann Hematol. 2000;79:581-584.
12. Filipovich A, McClain K, Grom A. Histiocytic disorders: Recent insights into pathophysiology and practical guide-lines. Biol Blood Marrow Transplant. 2010;16:S82-S89.
13. Makras P, Alexandraki KI, Chrousos GP, Grossman AB, Kaltsas GA. Endocrine manifestations in Langerhans cell histiocytosis. Trends Endocrinol Metab. 2007;18:252-257.
14. Aricò M, Girschikofsky M, Généreau T, et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer. 2003;39:2341-2348.
15. Grois N, Pötschger U, Prosch H, et al. Risk factors for diabetes insipidus in Langerhans cell histiocytosis. Pediatr Blood Cancer. 2006;46:228-233.
16. Newman B, Hu W, Nigro K, Gilliam AC. Aggressive histiocytic disorders that can involve the skin. J Am Acad Dermatol. 2007;56:302-316.
17. Wilson MS, Weiss LM, Gatter KC, Mason DY, Dorfman RF, Warnke RA. Malignant histiocytosis. A reassess-ment of cases previously reported in 1975 based on par-affin section immunophenotyping studies. Cancer. 1990; 66:530-536.
18. Asano T, Goto Y, Kida S, Ohno K, Hirakawa K. Isolated histiocytosis X of the pituitary stalk. J Neuroradiol. 1999; 26:277-280.
19. Scholz M, Firsching R, Feiden W, Breining H, Brechtelsbauer D, Harders A. Gagel's granuloma (local-ized Langerhans cell histiocytosis) in the pituitary stalk. Clin Neurol Neurosurg. 1995;97:164-166.
20. Harms PW, Schmidt LA, Smith LB, et al. Autopsy find-ings in eight patients with fatal H1N1 influenza. Am J Clin Pathol. 2010;134:27-35.
21. Kimura K, Adlakha A, Simon PM. Fatal case of swine influenza virus in an immunocompetent host. Mayo Clin Proc. 1998;73:243-245.
22. Imashuku S. Differential diagnosis of hemophagocytic syndrome: Underlying disorders and selection of the most effective treatment. Int J Hematol. 1997;66:135-151.